News Focus
News Focus
Followers 15
Posts 768
Boards Moderated 0
Alias Born 03/01/2005

Re: ksviking12 post# 5954

Friday, 01/07/2011 12:05:07 AM

Friday, January 07, 2011 12:05:07 AM

Post# of 97213
November 2009, ISCR had 50 million shares out with quarterly revenues of 4.5 million. A gain on settlement of debt was allowed for 1.45 million, which over 50 million shares represented 3 cents per share in earnings.
At the time, the market saw fit to value ISCR at 29 cents per share.
Today, there are about 100 million shares out due to all note and debt conversions, which means we would need to see about 3 million in income to see 3 cents per share in earnings.
The company has turned the profitablity quarter and most debt is eliminated, profit margins have increased, expenses are decreasing. Customers are increasing.
Even without the launch of these 2 massive products, the company on its current track could rack in 1.5 cents in earnings per quarter solely based off of the cleaned up balance sheet.
If the patent office approves their patent for MD @ Hand or if Genstrip takes off "as it sure looks like it did judging by the overwhelming demand from pre sales of 1.5 mil boxes" then the earnings per share could blow everyone away.

Lets take worst case scenario of 1.5 cents a share per quarter in earnings. Given investors saw fit to value this at 29 cents based off of 3 cents due to a one time extinguishment of debt, at 50 mil shares with 3 cents in one time earnings, we saw 29 cents. It traded at a yearly multiple of 10 times earnings per share.

At 1.5 cents in earnings per quarter thats 6 cents in a year. At a 10 times multiple we could trade at 60 cents.

Earnings multiples in Healthcare used to be in the 30's. Which would bode well for us, obviously. At some point as we break out and people see emerging growth, we may get valued at 50 times earnings or more like Yahoo was when it traded at 1200 times earnings in 1998. People saw the potential then.

I feel after this conference call, people will see the potential of ISCR. The Sales guidance of this new Genstrip will be the next leg of confidence and then the 10k will show the proof. By that time, ISCR could be valued at 30 times what we are trading at.

I smell value and for traders, fun times ahead.
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y